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1. INTRODUCTION 
The cyclic AMP (CAMP) receptor protein (CRP), 
also called catabolite activator protein (CAP), is a 
regulatory protein which controls expression of sev- 
eral catabolite-sensitive operons in Escherichia 
coli [l-6]. Typically, the CAMP * CRP complex sti- 
mulates transcription of certain catabolite genes but 
it is also known to shut off expression of several 
other genes [7-91 and to interfere with natural po- 
larity of polycistronic units [lo]. The protein has M, 
45 000 and it is composed of 2 apparently identical 
subunits [ll]. In the presence of CAMP limited 
proteolytic digestion of CRP with subtilisin results 
in a resistant N-terminal core, a-CRP, which retains 
the dimeric structure and CAMP binding activity 
but has lost CAMP-dependent DNA-binding capa- 
city at pH 8 as judged by the nitrocellulose filter 
assay [12,13]. However, from a thermal denatura- 
tion study on double-stranded poly [d(AT)] we 
have shown that a-CRP stabilizes the double- 
stranded structure of the polynucleotide and 
that this effect is modulated by CAMP [14]. This 
observation demonstrates that part of the 
CAMP-dependent DNA binding capacity is still 
present in the N-terminal fragment. The unique 
nucleic acid sequence of the crp gene coding for 
CRP has been established by 2 independent groups 
[15,16]. Although the agreement is good between 
the amino acid compositions predicted from this 
sequence and the published chemical analysis, some 
doubt exists as to the precise nature of the amino 
acid sequence at the N- and C-termini [15,16]. 
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Terminal sequence CA MP-binding fragment 
Therefore, we have determined the amino acid 
composition and the N- and C-terminal partial se- 
quence of CRP purified from a wild-type strain and 
a super-producing strain [ 151 and have located the 
unique cleavage point which generates cw-CRP by 
subtilisin limited digestion. 
2. EXPERIMENTAL 
CRP was purified to homogeneity as outlined in 
[ 171 from two E. coli K-12 strains, namely KLF 
41/JC 1553 employed previously and a strain con- 
taining recombinant plasmid pBScrp2 in [ 151. In cell 
extracts of the latter strain, the protein concentra- 
tion, estimated from CAMP binding capacity, in- 
creased -40-fold, and this value was consistent 
(N. Guiso, personal communication) with the value 
obtained by radioimmuno-assay [ 181. Purity of both 
protein preparations of CRP was of the order of 
99% as estimated from SDS-polyacrylamide gel 
electrophoresis. 
(u-CRP was prepared essentially as in [ 131 in the 
following way. For each particular batch of subtili- 
sin (Sigma type VII n. P-5255), small-scale digestion 
assays were carried out in order to optimize the ratio 
of the protease to CRP. Under optimal conditions 
non-digested CRP was practically undetectable and 
a single polypeptide band (app. M, 12 500 + 500) 
without any visible contaminant was observed on a 
15% SDS-polyacrylamide gel. Typically, a solution 
0.4 mg CRP/ml in 0.1 M NaCl, 10 mM Tris-HCl, 1 
mM EDTA (pH 8) containing 1 mM CAMP was 
digested with 8.5 pg subtilisin/ml for 15 min at 
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37°C. The reaction was stopped with 1 mM phenyl- 
methanesulfonyl fluoride (PMSF), and the mix- 
ture dialysed against 50 mM NaCl, 15 mM phos- 
phate, 0.5 mM EDTA, 1 mM PMSF (pH 6.8). From 
the dialysed solution (u-CRP was adsorbed on a 
column of Bio-Rex 70, washed with the same buffer 
(except for PMSF) and eluted by implementing the 
buffer with 1 M NaCl. A second chromatography 
step may be necessary to remove any trace of CAMP 
which can be ascertained from the value of the 
absorbance ratio A 280/A 260. 
Proteins and peptides (- 5 pg) were hydrolysed 
with a mixture of CF$Z02H/HCl (1:2) for 25 and 
50 min at 166°C [19], which proved highly efficient 
for the hydrolysis of hydrophobic proteins. Amino 
acid analysis was conducted with Durrum D500 
analyser having a 2.5 nmol amino acid full scale 
detection. The value of cystine were determined 
with performic acid oxidized proteins after hydro- 
lysis [20] and those of tryptophan were analysed 
after micro-scale hydrolysis (unpublished) with 3 N 
methane sulfonic acid [21]. N-Terminal sequences 
were analysed with a Beckman 890C spinning cup 
sequanator [22] 3 mg polybrene (Pierce) was used as 
a carrier [23] in the spinning cup and washed 3 times 
by the normal protein program (0.1 M quadrol 
program from Beckman). The proteins, 30 nmol 
t 
“C]carboxymethylated (CM-) [24] a-CRP, 3 nmol 
4CM-CRP from the super producing strain and 0.3 
nmol CRP of the wild strain, were boiled in 1% SDS 
at 100°C for 5 min and subjected to double coup- 
ling in the first step. Dithioerythritol (Sigma) was 
added to the solvents [25]. After automatic conver- 
sion (P6 sequamat) to phenylthiohydantoin amino 
acids the analysis was made with high-pressure 
chromatography (Pye Unicam LC3) [22] and 
14CM-cysteine was identified by radioactivity. 
C-Terminal sequences were analysed by carboxy- 
peptidase (Cp) digestion followed by direct amino 
acid analysis [26]. The digestion buffers were 0.1 M 
pyridine-collidine acetate (pH 8.5) for CpA (Wor- 
thington Biochemicals, diisopropylfluorophos- 
phate (DFP)-treated)) and for CpB (Sigma, PMFS- 
treated and re-treated with DFP), 0.1 M pyri- 
dine acetate (pH 5.5) for CpY (Pierce) and 0.1 M 
pyridine formate (pH 2.5) for CpP (Takara- 
Shuzo, Kyoto). CP (5 pg) was added to l-2 nmol 
proteins and incubated for 6 h at 37°C. 
3. RESULTS AND DISCUSSION 
Table 1 shows the amino acid composition of 
CRP and of the subtilisin digestion product (u-CRP. 
Both compositions of CRPs from the super-produ- 
cing and the wild strains are essentially identical 
and comparable with [ 11,271. Major differences of 
the compositions from those derived from DNA 
sequence [15,16] are lower values of -2 mol iso- 
leucine and 1 mol methionine. The N-terminal 
methionine has been processed (see below) and iso- 
leucine may be due to insufficient hydrolysis. This 
was found also for (Y-CRP indicating the resistant 
isoleucyl peptide bonds to be in the (u-CRP. Values of 
histidine and lysine agreed with those deduced from 
the DNA sequence, while these amino acids were 
found to have lower values in [ 11,281, possibly due 
to the poor hydrolysis. Also our compositions of 
CRPs indicate the absence of processing at the 
C-terminal 3 amino acids, glycine, threonine and 
arginine (see below) and the loss of the N-terminal 
methionine. The partial N- and C-terminal se- 
quences of both CRP proteins and (u-CRP are pre- 
sented in Iig.1. CRP purified from the super-pro- 
ducing strain and ar-CRP prepared from it show 
redundancy at the N-termini, where 90% valine and 
-7% methionine were found. This N-terminal re- 
dundancy as well as an acid-labile peptide bond 
Asp-Pro (position 9-10) limited the extent of 
analysis up to residue 37-41, as the average yield 
per step was -97.5%. The N-terminal sequence we 
obtained here is completely coincident with the se- 
quence deduced from the DNA sequence including 
the presence of a glutamic acid residue at position 
13. Except for this position (reported as a glutamine) 
the sequence of the first 14 residues was kncwn 
[ 11,271 for CRP from a conventional strain, KLF 
41/JC 1553. With CRP purified from this strain the 
first step of Edman degradation revealed only 
traces of methionine (< 1.2%). The exact origin of 
the N-terminal redundancy observed with CRP 
from an’ over-producing strain cannot be ascer- 
tained from this sequence analysis. It may be 
caused by irregular posttranslational processing 
1291. 
The C-terminal amino acid of CRP purified from 
the 2 strains, arginine, of heat denatured protein 
(1OO’C for 1 min) was liberated almost quantita- 
tively by digestion with CpP. The other CpA and 
CpB digested the denatured protein resulting in the 
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Table 1 
Amino acid composition of CRP and a-CRP 
Hydro- 
lysis 
(min): 
CRP of the super- CRP of the wild- 
producing strain type strain 
CRP 
aCRP of the super- 
producing strain 
(uCRP 
25 50 Integer 24 50 Integer 
From DNA Previously 25 5. 
sequence reported 
Integer 
From DNA 
sequence 
ASP 13.0 13.0 13 13.0 13.0 13 13 14 15 6.0 6.0 6 6 
Thr 12.2 11.7 13 12.4 12.0 13 13 13 12 4.8 4.6 5 5 
Ser 10.1 8.8 11 9.6 8.6 11 11 9 10 6.9 6.2 7-8 7 
Glu 27.2 29.6 30 27.2 29.6 30 30 31 31 17.3 17.8 18 18 
Pro 6.0 6.0 6 5.8 6.0 6 6 7 6 4.2 4.4 4 4 
GlY 16.2 16.3 16 16.4 16.1 16 16 16 16 8.4 8.4 8 8 
Ala 13.5 13.3 13 13.3 13.4 13 13 12 14 6.5 6.4 6-7 6 
Val 11.5 13.7 14 11.1 14.1 14 14 14 13 6.2 7.2 7 7 
Met 5.9 3.7 6 5.5 5.2 6 7 5 5 1.9 1.4 2 2 
Ile 12.5 15.2 15 12.3 15.0 15 17 16 15 5.8 7.3 7 9 
Leu 18.3 22.0 22 20.0 21.6 22 22 21 22 11.1 11.5 12 12 
TYr 5.8 5.7 6 5.7 5.4 6 6 5 5 4.7 4.2 5 5 
Phe 4.7 4.9 5 4.6 4.5 5 5 5 5 3.6 3.5 4 4 
His 5.4 5.7 6 5.0 5.8 6 6 5 5 2.8 3.5 4 4 
LYs 14.2 14.6 15 14.3 14.7 15 15 13 14 8.7 9.5 9-10 10 
A rg 10.8 10.6 11 11.3 11.0 11 11 10 9 4.4 4.5 4-5 4 
cys/2 3.0 3a 2.9 3 3 2 2 1.6 2a 2 
Trp 1.7 2 1.9 2 2 2 2 1.8 2 2 
From 
DNA Seq. 
a-CP.P 
CRP(S) 
CRP(W) 
Cl-CRP 
CRP(S) 
CRP(W) 
a-CRP 
CRP(S) 
CRP(W) 
a These values are also observed by titration with DTNB of the denatured proteins (unpublished) 
ATG GTG . . . . . 5 10 15 14 CM 20 25 
Met Val Leu Gly Lys Pro Gin Thr Asp Pro Thr Leu Glu Trp Phe Leu Ser His Cys His Ile His Lys Tyr Pro 
30 35 40 45 50 
Ser Lys Ser Thr Leu Ile His Gln Gly Glu Lys Ala Glu Thr Leu Tyr Tyr Ile Val Lys Gly Ser Val Ala Val 
110 115 205 210 
--_ -__ ___ _-- --- --- -__ 
Asp Pro Asp Ile Leu Met Arg Leu Thr Ile Val Val Tyr Gly Thr Arg 
r-r-r--I---v--AB 
-c--A 
P 
.._ -_-__- r-- --- --- -AB r--r---cp 
7 
___ ___ ___ _. ~--T-- --- --- ,- - r,---,---AAB 
Fig.1. Partial sequence of CRP from the super producing strain (S) and the wild strain (W) and a-CRP. 
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C-terminal sequence as (Ile,Val)-Tyr-Glu-Thr- 
Arg with a recovery of 40% arginine (see tig.1). 
The results.clearly indicate that the C-terminus of 
the CRP polypeptide chain is an arginine residue, 
and this is consistent with the DNA sequence (Arg 
210). In contrast, CpY digestion resulted in the 
amino acids of the C-terminal region to be He, Leu, 
Val and Tyr [28]. Together with the DNA sequence 
data their results suggest that some kind of proces- 
sing or cleavage of a C-terminal tripeptide may 
have occurred either in vivo or in the course of the 
extraction and purification procedures [ 15,161. We 
have also digested CRP with CpY and observed 
liberation of similar amino acids but only in very 
small amounts (< 5%). In the presence of pepstatine 
A (Sigma), which is known to inhibit contaminating 
proteases present in preparation of carboxypepti- 
dase Y [30], the liberation of these amino acids was 
markedly reduced. Altogether, the results suggest 
that the hypothesis of a processing at the C-terminal 
of the CRP chain is rather unlikely. 
We have found the N-terminal sequence of 
a-CRP identical with that of the native protein in- 
cluding N-terminus redundancy in the case of the 
preparation from the super-producing strain. This 
is at variance with [27] where as much as 65% of the 
(u-CRP molecules had lost a N-terminal dipeptide. 
We show here that carefully adjusted conditions for 
subtilisin digestion, derived from the original con- 
ditions in [13], permits preparation of (w-CRP with 
the N-terminus retaining intact. Kinetics of di- 
gestion of a-CRP with CpA and a mixture of A and B 
revealed that the C-terminal sequence of the core 
fragment is (Ile-Leu)-Met-Arg-Leu (tig.1). This 
sequence overlaps with positions 113-l 17 in the 
sequence of the native protein predicted from the 
DNA sequence. From the amino acid composition 
(table 1) and the N- and C-terminal sequences we 
thus conclude that (u-CRP is the intact N-terminal 
fragment of the CRP polypeptide chain spanning 
the sequence from Val(2) to Leu (117). The C-ter- 
minal leucine of (w-CRP is consistent with the 
known specificity of subtilisin. From the yield of 
C-terminal leucine, we can estimate that homo- 
geneity of the a-CRP is 2 95%. 
From a 2.9 A resolution X-ray crystallographic 
analysis, a model of the structure of the CAMP - 
CRP complex has been published [31]. With this 
model and the available sequence [15,16] we ob- 
serve that (r-CRP lacks a large part (%--%) of the 
long C a-helix of the polypeptide backbone along 
which contacts are established between the 2 chains 
in the dimer. However, we note that the stability of 
the dimeric state of (Y-CRP in solution is 
at least as good as that of native CRP (unpublished). 
Though not active on transcription in vitro 
(unpublished) this well-defined derivative of CRP 
is worthy of interest for structure analysis and it 
may help unravel important aspects of structu- 
re-function relationships in this regulatory protein. 
Particularly puzzling is the way by which structural 
information originating in the CAMP binding do- 
main may be transferred to the C-terminal region of 
the molecule with a modulation of its DNA-binding 
properties. 
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